GENE ONLINE|News &
Opinion
Blog

Type 1 Diabetes
GeneOnline’s Weekly News Highlights: June 26-30
2023-07-03
Vertex and Lonza Collaborate to Revolutionize Type 1 Diabetes Treatment
2023-06-29
Novo Nordisk and Aspect Team Up to Develop Bioprinting-Based Diabetes Treatment
2023-04-13
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
Provention’s Tzield Snags FDA’s Approval to Slow Type 1 Diabetes Progression
2022-11-20
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
Medtronic Bags FDA Authorization for Pioneering Medical Device to Combat Pediatric Diabetes
2020-09-02
Newly Created Immune-Evading Human Islets Could Potentially Treat Diabetes
2020-08-24
R&D
Diabetes: Novel Amylin, Insulin Coformulation Could Aid Blood-Sugar Control
2020-05-14
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top